GotoPER - Physicians' Education Resource
Back to Home
Free CE/CMEVideo

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Create AccountAlready Registered? Login Here

Release Date

July 11, 2025

Expiration Date

July 12, 2026

Credits

2.0 CME, NCPD

Specialties

Lung Cancer, Nursing Oncology+1 more

Release Date: July 11, 2025

Expiration Date: July 11, 2026

Activity Overview

This educational activity is an archive of the live presentation held on Sunday, June 1, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, nurse practitioners, physician assistants, and other health care providers involved in the treatment and management of non–small cell lung cancer (NSCLC).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Outline current and emerging approaches targeting HER2 in the management of advanced or metastatic NSCLC
  • Evaluate emerging evidence and the potential place in the treatment algorithm for novel approaches targeting TROP2 in advanced or metastatic NSCLC
  • Discuss potential strategies for optimizing outcomes, including toxicity management, with current and emerging therapies targeting HER2 and TROP2 in the management of advanced or metastatic NSCLC
Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc; AstraZeneca Pharmaceuticals; and Daiichi Sankyo, Inc.

Related Content

Course

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Create Account